CerraCap Ventures, an early-stage venture capital firm specializing in cyber security, advanced analytics, and health-tech investments, has invested in sleep and respiratory software company Somnoware. This strategic investment from CerraCap Ventures is poised to accelerate Somnoware’s expansion in sleep, respiratory care, and additional healthcare markets.

Somnoware’s mission is to reduce chronic respiratory disease healthcare costs and improve patient outcomes by enabling early diagnosis and more effective chronic care management.

Somnoware’s platform orchestrates data flow between 100+ medical devices, unifies datasets within a single platform, delivers analytics, enables faster diagnosis, proactive intervention, and automated patient engagement. More than 1,500 diagnostic testing centers use Somnoware.

“With the goal of further solidifying its position as the leading respiratory healthcare management platform, we are excited about the future of the Somnoware platform to transform this space. Their solution is well-designed for their end-users, and its platform is experiencing major expansion. We are bullish about their revenue traction and large iconic client base,” says Saurabh Ranjan, founder and CEO of CerraCap Ventures, in a release.

Subath Kamalasan, founder and CEO of Somnoware, says in a release, “Healthcare systems realize now more than ever that workflow automation and access to meaningful data is vital to improving healthcare outcomes and reducing costs. This is why we see increasing demand for a platform that enables healthcare systems to integrate systems and devices, consolidate data, and proactively engage with patients to improve care. This new investment from CerraCap Ventures will accelerate Somnoware’s expansion into new markets and boost adoption of our platform by healthcare systems nationwide.”